دورية أكاديمية

Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey:An Illustration Based on Bursa Data

التفاصيل البيبلوغرافية
العنوان: Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey:An Illustration Based on Bursa Data
المؤلفون: Pouwels, Koen B., Bozdemir, Sefika E., Yegenoglu, Selen, Celebi, Solmaz, McIntosh, E. David, Unal, Serhat, Postma, Maarten J., Hacimustafaoglu, Mustafa
المصدر: Pouwels , K B , Bozdemir , S E , Yegenoglu , S , Celebi , S , McIntosh , E D , Unal , S , Postma , M J & Hacimustafaoglu , M 2016 , ' Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey : An Illustration Based on Bursa Data ' , PLoS ONE , vol. 11 , no. 9 , e0163567 . https://doi.org/10.1371/journal.pone.0163567Test
سنة النشر: 2016
المجموعة: University of Groningen research database
مصطلحات موضوعية: RESPIRATORY-SYNCYTIAL-VIRUS, YOUNG-CHILDREN, UNITED-STATES, TRACT INFECTIONS, HIGH-RISK, INFLUENZA, MORTALITY, HOSPITALIZATION, AGE, NETHERLANDS
الوصف: Background Worldwide, respiratory syncytial virus (RSV) is considered to be the most important viral cause of respiratory morbidity and mortality among infants and young children. Although no active vaccine is available on the market yet, there are several active vaccine development programs in various stages. To assess whether one of these vaccines might be a future asset for national immunization programs, modeling the costs and benefits of various vaccination strategies is needed. Objectives To evaluate the potential cost-effectiveness of RSV vaccination of infants and/or pregnant women in Turkey. Methods A multi-cohort static Markov model with cycles of one month was used to compare the cost-effectiveness of vaccinated cohorts versus non-vaccinated cohorts. The 2014 Turkish birth cohort was divided by twelve to construct twelve monthly birth cohorts of equal size (111,459 new-borns). Model input was based on clinical data from a multicenter prospective study from Bursa, Turkey, combined with figures from the (inter) national literature and publicly available data from the Turkish Statistical Institute (TUIK). Incremental cost-effectiveness ratios (ICERs) were expressed in Turkish Lira (TL) per quality-adjusted life year (QALY) gained. Results Vaccinating infants at 2 and 4 months of age would prevent 145,802 GP visits, 8,201 hospitalizations and 48 deaths during the first year of life, corresponding to a total gain of 1650 QALYs. The discounted ICER was estimated at 51,969 TL (26,220 US $ in 2013) per QALY gained. Vaccinating both pregnant women and infants would prevent more cases, but was less attractive from a pure economic point of view with a discounted ICER of 61,653 TL (31,106 US $ in 2013) per QALY. Vaccinating only during pregnancy would result in fewer cases prevented than infant vaccination and a less favorable ICER. Conclusion RSV vaccination of infants and/or pregnant women has the potential to be cost-effective in Turkey. Although using relatively conservative assumptions, all evaluated ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: https://research.rug.nl/en/publications/4d3d4d9d-c9bb-4455-8870-62aef65e6a7dTest
DOI: 10.1371/journal.pone.0163567
الإتاحة: https://doi.org/10.1371/journal.pone.0163567Test
https://hdl.handle.net/11370/4d3d4d9d-c9bb-4455-8870-62aef65e6a7dTest
https://research.rug.nl/en/publications/4d3d4d9d-c9bb-4455-8870-62aef65e6a7dTest
https://pure.rug.nl/ws/files/40479167/Potential_Cost_Effectiveness_of_RSV_Vaccination_of_Infants_and_Pregnant_Women_in_Turkey.PDFTest
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.32519B8E
قاعدة البيانات: BASE